Covered Call Analyzer CONSERVATIVE "STOCKS-TO-CONSIDER"
for June, 2005
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
Sep Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
Photon Dynamics | PHTN | $18.11 | 500 | $9,075 | PDUGX | $0.50 | $23 | 22.5 | 27% | +$2,408 | +27% |
| Comments: |
Called. |
||||||||||
| Imergent, Inc. | IIG | $11.20 | 800 | $8,980 | IIGGV | $0.55 | $418 | 12.5 | 16% | ($906) | -10% |
| Comments: |
Not called. Sold Aug12.5 at 0.25. Not called. Exercised get-out price at $9.52 after buying back calls at 0.17. |
||||||||||
|
Olympic Steel |
ZEUS |
$15.95 |
600 |
$9,590 |
SBQGW |
$0.45 |
$251 |
17.5 |
12% |
($1,305) | -14% |
| Comments: |
Exercised get-out price at $13.56 after buying back calls at 0.17. |
||||||||||
|
Blue Coat Systems |
BCSI |
$27.67 |
300 |
$8,321 |
IYUGF |
$0.70 |
$196 |
30 |
10% |
+$875 |
+11% |
|
Comments: |
Called. |
||||||||||
| Career Education | CECO | $37.31 | 200 | $7,482 | CUYGH | $1.05 | $197 | 40 | 10% | +$715 | +10% |
| Comments: |
Called. |
||||||||||
| Allegheny Technology | ATI | $23.29 | 400 | $9,336 | ATIGE | $0.40 | $144 | 25 | 9% | +$808 | +9% |
| Comments: |
Called. |
||||||||||
|
First Horizon Pharma |
FHRX |
$18.85 | 500 | $9,445 | FUFGD | $0.50 | $233 | 20 | 8% | +$788 | +8% |
| Comments: |
Called. |
||||||||||
|
Apple Computer |
AAPL |
$38.16 |
200 |
$7,652 |
AAQGH |
$1.35 |
$257 |
40 |
8% |
+$605 | +8% |
| Comments: |
Called. |
||||||||||
|
Multimedia Games |
MGAM | $12.00 | 800 | $9,620 | QMGGV | $0.40 | $298 | 12.5 | 7% | ($994) | -10% |
| Comments: |
Not called. Sold Aug12.5 at 0.45. Exercised get-out price at $10.20 after buying back calls at 0.21. |
||||||||||
|
Symantec Corp. |
SYMC | $21.60 | 400 | $9,336 | SYQGX | $0.50 | $144 | 22.5 | 6% | +$524 | +6% |
| Comments: |
Called. |
||||||||||
|
All positions closed out with value up +$3,517. |
|||||||||||
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.